Prestige Consumer Healthc...

NYSE: PBH · Real-Time Price · USD
85.68
1.20 (1.42%)
At close: May 30, 2025, 3:59 PM
85.67
-0.01%
After-hours: May 30, 2025, 05:30 PM EDT

Prestige Consumer Healthcare Revenue Breakdown

Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2018 Mar 31, 2017 Mar 31, 2016 Mar 31, 2015
Analgesics Revenue 117.7M 117.45M 119.42M 122.17M 119.47M 114.55M
Analgesics Revenue Growth +0.21% -1.65% -2.26% +2.27% +4.29% n/a
Cough and Cold Revenue 106.21M 119.02M 111.85M 108.78M 116.57M 121.77M
Cough and Cold Revenue Growth -10.76% +6.41% +2.81% -6.68% -4.27% n/a
Dermatologicals Revenue 128.95M 129.1M 96.89M 87.35M 85.07M 67.09M
Dermatologicals Revenue Growth -0.12% +33.25% +10.92% +2.68% +26.80% n/a
Eye and Ear Care Revenue 183.32M 179.42M 104.05M 109.69M 107.5M 97.92M
Eye and Ear Care Revenue Growth +2.17% +72.44% -5.14% +2.04% +9.78% n/a
Gastrointestinal Revenue 255.94M 231.61M 152.24M 101.31M 94.59M 96.97M
Gastrointestinal Revenue Growth +10.51% +52.14% +50.26% +7.11% -2.46% n/a
Oral Care Revenue 95.03M 96.31M 111M 108.1M 51.13M 46.4M
Oral Care Revenue Growth -1.32% -13.24% +2.69% +111.44% +10.19% n/a
Other OTC Revenue 13.78M 12.03M 5.71M 5.83M 6.1M 6.21M
Other OTC Revenue Growth +14.58% +110.74% -2.11% -4.43% -1.87% n/a
Women's Health Revenue 236.83M 240.42M 259.38M 150.88M 135.17M 73.77M
Women's Health Revenue Growth -1.49% -7.31% +71.91% +11.63% +83.23% n/a

Revenue by Geography

Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2017 Mar 31, 2016 Mar 31, 2015
North American Otc Healthcare Revenue 960.01M 958.26M 2.89B 2.63B 2.26B
North American Otc Healthcare Revenue Growth +0.18% -66.81% +9.62% +16.72% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 64.05M 64.13M 67.48M 68.28M 63.98M 65.47M 66.1M 63.92M 58.53M 56.96M 70.26M 66.67M 64.75M 66.22M 72.98M 61.91M 60.24M 59.48M 58.73M 47.68M 63.75M 54.87M 61.18M 56.51M 55.73M 54.99M 61.08M 61.05M 157.13M 57.04M 60.76M 57.28M 70.21M 52.81M 47.39M 47.09M 46.78M 48.07M 44.35M 44.01M 43.05M
Selling, General, and Administrative Revenue Growth -0.11% -4.96% -1.17% +6.71% -2.27% -0.95% +3.41% +9.20% +2.77% -18.93% +5.39% +2.97% -2.23% -9.26% +17.88% +2.77% +1.28% +1.27% +23.16% -25.20% +16.19% -10.32% +8.27% +1.39% +1.35% -9.97% +0.04% -61.15% +175.47% -6.11% +6.07% -18.42% +32.94% +11.45% +0.63% +0.66% -2.68% +8.38% +0.78% +2.23% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue 37M 37.95M 41.41M 39.37M 37.52M 39.47M 40.1M 36.23M 30.87M 30.42M 43.82M 39.95M 36.94M 40.24M 40.73M 39.44M 36.42M 38.08M 38.34M 27.75M 40.17M 33.56M 38.67M 34.8M 34.43M 34.5M 37.04M 37.11M 35.32M 35.84M 39.19M 36.94M 41.45M 30.68M 28.59M 27.64M 26.55M 29.93M 27.89M 26.42M 25.37M
Sales and Marketing Revenue Growth -2.48% -8.37% +5.19% +4.93% -4.94% -1.59% +10.68% +17.37% +1.46% -30.57% +9.68% +8.17% -8.21% -1.21% +3.27% +8.30% -4.37% -0.68% +38.17% -30.91% +19.69% -13.21% +11.11% +1.07% -0.21% -6.85% -0.19% +5.07% -1.44% -8.56% +6.07% -10.87% +35.10% +7.31% +3.46% +4.08% -11.30% +7.32% +5.57% +4.16% n/a